Pfizer Gets CDSCO Panel Nod To Study Anti-cancer Drug PF-07220060 Dr. Divya Colin9 Jan 2025 6:00 PM ISTNew Delhi: The drug major Pfizer has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Addition of AstraZeneca breast cancer drug Enhertu to China state insurance list Ruchika Sharma29 Nov 2024 5:29 PM ISTChina: Enhertu, a blockbuster breast cancer drug of AstraZeneca, will be included in China's state-run health insurance scheme from January 1, as per...
Despite Pluvicto, MorphoSys Setbacks, Novartis Raises 2028 Sales Growth Outlook to 6% Farhat Nasim24 Nov 2024 10:30 AM ISTFrankfrut: Novartis raised its medium-term sales guidance on Thursday to 6 percent annual growth through 2028, driven by momentum of launched...
Zydus barred from selling cancer drug Sigrima as Delhi HC restores injunction in favour of Roche Farhat Nasim16 Nov 2024 3:25 PM ISTNew Delhi: Upholding the patent rights of Swiss pharmaceutical giant F-Hoffmann-La Roche AG, the Delhi High Court has once again reinstated an...
Medical Bulletin 3/October/2023 Isra Zaman3 Oct 2023 3:15 PM ISTHere are the top medical news of the day:Common breast cancer drug Alpelisib may have an alarming side effect, finds studyA recent retrospective study...
Novartis lifts full year earnings on higher prescriptions Ruchika Sharma25 April 2023 11:37 AM ISTFirst-quarter group sales gained 3 percent to $12.95 billion, above an analyst consensus of $12.55 billion, driven by better than expected revenues...
Novartis buoyed by trial success in early-stage breast cancer Ruchika Sharma29 March 2023 9:15 AM ISTFrankfurt: Novartis's Kisqali breast cancer drug cut the risk of recurrence in women who were diagnosed at an early stage of the disease in a pivotal...
Pfizer, Bristol Myers, AbbVie drugs likely to face US price negotiation Ruchika Sharma14 March 2023 3:30 PM ISTNovo Nordisk's diabetes drug Ozempic, prostate cancer treatment Xtandi from Astellas Pharma and Pfizer, and J&J's blood thinner Xarelto are on three...
Gilead Sciences secures USFDA okay for Trodelvy for pre-treated HR+/HER2- Metastatic Breast Cancer Ruchika Sharma4 Feb 2023 11:37 AM ISTTrodelvy (sacituzumab govitecan-hziy) is a first-in-class Trop-2 directed antibody-drug conjugate.
Alkem launches novel breast cancer treatment drug Palbociclib under brand name Palbo Dr. Nandita Mohan18 Jan 2023 11:15 AM ISTPalbo comes in capsule form in multiple dose strengths with varied pricing ranges, including 125mg at INR 6125/- for 21 capsules, 100mg at Rs. 6062/-,...
Dr Reddy's Labs acquires trademark rights of breast cancer drug from Pfizer Ruchika Sharma16 Jan 2023 11:00 AM ISTThe in-house product will be retailed in the Indian market at a reduction of 85% from the current MRP to increase affordability and access to...
Lupin, Zydus Lifesciences recall products in US over manufacturing issues Ruchika Sharma3 Sept 2022 12:03 PM ISTNew Delhi: Home-grown drug makers Zydus Lifesciences and Lupin are recalling products in the US, the world's largest market for medicines, due to...
